The authors regret the affiliation of Dr Paolo Pedrazzoli was incorrectly given in the original article. Dr Pedrazzoli's correct affiliation should read as follows: 24Medical Oncology, Fondazione IRCCS Policlinico S. Matteo and Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy The authors would like to apologise for any inconvenience caused.
Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] (Annals of Oncology (2022) 33(57-66) (S0923753421044963), (10.1016/j.annonc.2021.09.017))
Novello S.;Morabito A.;Pedrazzoli P.;
2022-01-01
Abstract
The authors regret the affiliation of Dr Paolo Pedrazzoli was incorrectly given in the original article. Dr Pedrazzoli's correct affiliation should read as follows: 24Medical Oncology, Fondazione IRCCS Policlinico S. Matteo and Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy The authors would like to apologise for any inconvenience caused.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
